mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.7 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |